Publication Information

{'id': 'https://openalex.org/W3122290934', 'doi': 'https://doi.org/10.13345/j.cjb.200220', 'title': '[Research progress of new vaccine adjuvants].', 'display_name': '[Research progress of new vaccine adjuvants].', 'publication_year': 2021, 'publication_date': '2021-01-25', 'ids': {'openalex': 'https://openalex.org/W3122290934', 'doi': 'https://doi.org/10.13345/j.cjb.200220', 'mag': '3122290934', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/33501791'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/33501791', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'review', 'type_crossref': 'journal-article', 'indexed_in': ['pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.151, 'has_fulltext': False, 'cited_by_count': 5, 'citation_normalized_percentile': {'value': 0.16089, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 79, 'max': 81}, 'biblio': {'volume': '37', 'issue': '1', 'first_page': '78', 'last_page': '87'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11725', 'display_name': 'Immunodeficiency and Autoimmune Disorders', 'score': 0.9571, 'subfield': {'id': 'https://openalex.org/subfields/2403', 'display_name': 'Immunology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11725', 'display_name': 'Immunodeficiency and Autoimmune Disorders', 'score': 0.9571, 'subfield': {'id': 'https://openalex.org/subfields/2403', 'display_name': 'Immunology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10340', 'display_name': 'Hepatitis B Virus Studies', 'score': 0.9559, 'subfield': {'id': 'https://openalex.org/subfields/2713', 'display_name': 'Epidemiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12025', 'display_name': 'Hepatitis Viruses Studies and Epidemiology', 'score': 0.9232, 'subfield': {'id': 'https://openalex.org/subfields/2721', 'display_name': 'Hepatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/vaccine-adjuvant', 'display_name': 'Vaccine adjuvant', 'score': 0.5891292}], 'concepts': [{'id': 'https://openalex.org/C3020289777', 'wikidata': 'https://www.wikidata.org/wiki/Q967453', 'display_name': 'Vaccine adjuvant', 'level': 3, 'score': 0.5891292}, {'id': 'https://openalex.org/C2777863537', 'wikidata': 'https://www.wikidata.org/wiki/Q357896', 'display_name': 'Adjuvant', 'level': 2, 'score': 0.38618684}, {'id': 'https://openalex.org/C159047783', 'wikidata': 'https://www.wikidata.org/wiki/Q7215', 'display_name': 'Virology', 'level': 1, 'score': 0.37518433}, {'id': 'https://openalex.org/C70721500', 'wikidata': 'https://www.wikidata.org/wiki/Q177005', 'display_name': 'Computational biology', 'level': 1, 'score': 0.32204443}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.3044895}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.20981005}], 'mesh': [{'descriptor_ui': 'D000276', 'descriptor_name': 'Adjuvants, Immunologic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D014612', 'descriptor_name': 'Vaccines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D000276', 'descriptor_name': 'Adjuvants, Immunologic', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D005620', 'descriptor_name': "Freund's Adjuvant", 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D022223', 'descriptor_name': 'Vaccines, Subunit', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/33501791', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3113762720', 'https://openalex.org/W3032757515', 'https://openalex.org/W2950739693', 'https://openalex.org/W2626840463', 'https://openalex.org/W2392404409', 'https://openalex.org/W2348609965', 'https://openalex.org/W2135221251', 'https://openalex.org/W2110926211', 'https://openalex.org/W2105963031', 'https://openalex.org/W2036465153'], 'abstract_inverted_index': {'In': [0], 'recent': [1], 'years,': [2], 'the': [3, 73, 77, 104, 111, 129], 'development': [4, 130], 'of': [5, 65, 107, 131], 'new': [6, 89, 95, 126], 'vaccines': [7, 19, 33, 91], 'such': [8, 37], 'as': [9, 38], 'nucleic': [10], 'acid': [11], 'vaccines,': [12, 15, 31], 'genetically': [13], 'engineered': [14], 'and': [16, 50, 85, 120], 'synthetic': [17], 'peptide': [18], 'has': [20], 'achieved': [21], 'rapid': [22], 'development.': [23], 'However,': [24], 'compared': [25], 'with': [26, 110], 'traditional': [27], 'inactivated': [28], 'or': [29], 'live': [30], 'these': [32], 'often': [34], 'have': [35, 52], 'problems': [36], 'poor': [39], 'immunogenicity.': [40], 'Therefore,': [41], 'an': [42], 'adjuvant': [43, 84, 119], 'is': [44], 'needed': [45], 'to': [46, 54, 102], 'enhance': [47], 'its': [48], 'effect,': [49], 'adjuvants': [51, 81], 'proven': [53], 'be': [55], 'a': [56], 'key': [57], 'component': [58], 'in': [59], 'vaccines.': [60], 'There': [61], 'are': [62, 82], 'many': [63], 'types': [64], 'adjuvants,': [66, 109], 'while': [67], 'currently': [68], 'no': [69], 'unified': [70], 'standard': [71], 'for': [72, 128], 'classification.': [74], 'At': [75], 'present,': [76], 'most': [78], 'commonly': [79], 'used': [80], 'Aluminum': [83], "Freund's": [86], 'adjuvant,': [87, 116], 'but': [88], 'generation': [90, 96], 'will': [92], 'probably': [93], 'need': [94], 'adjuvants.': [97], 'Thus,': [98], 'this': [99], 'review': [100, 124], 'aims': [101], 'showcase': [103], 'current': [105], 'status': [106], 'immune': [108], 'focus': [112], 'on': [113], 'immunomodulatory': [114], 'molecular': [115], 'antigen': [117], 'delivery': [118], 'compound': [121], 'adjuvant.': [122], 'This': [123], 'provides': [125], 'insights': [127], 'novel': [132], 'vaccine': [133], 'adjuvants.近年来，核酸疫苗、基因工程疫苗、合成肽疫苗等新型疫苗的研究取得快速的发展，但这些疫苗与传统的灭活或活体疫苗相比，往往存在免疫原性差等问题，因此需要佐剂来增强其作用。佐剂已被证明是疫苗中的关键成分，佐剂种类众多，尚无统一的分类方法，目前应用最多的佐剂是铝佐剂和弗氏佐剂，但随着新型疫苗的开发，新型佐剂的开发必不可少。根据目前佐剂的研究现状，主要从免疫调节分子类佐剂、抗原递送类佐剂、复合佐剂3个方面进行分析阐述，以期对佐剂的研制提供参考。.': [134]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W3122290934', 'counts_by_year': [{'year': 2024, 'cited_by_count': 3}, {'year': 2023, 'cited_by_count': 2}], 'updated_date': '2024-12-16T15:15:31.430648', 'created_date': '2021-02-01'}